Quick Intro

ReSurfX is an outcomes intelligence technology company improving innovation and ROI from data-intensive activities of enterprises to enhance insights, automate knowledge extraction, and predict outcome directions in advance. With a focus on the healthcare sector, we empower experts to add superior value to their enterprises through our novel data-source agnostic machine learning approach, 'Adaptive Hypersurface Technology' (AHT). Our AI solutions, such as Advance Outcomes Alert System (AOAS), help deliver unprecedented prediction capabilities with superior accuracy, robustness, and novel insights.

Our enterprise SaaS product ReSurfX::vysen is one of the most accurate in the market, offering best-in-class functionalities and use configurations at scale. Its powerful predictor, SyRTOP (Systems Response-based Triggers and Outcomes Predictor), demonstrates unprecedented prediction power, providing novel insights and advance predictions of outcome directions—a core component of AOAS.

The extreme focus of ReSurfX on reliable AI solutions, coupled with the novel AHT approach at the core, has consistently necessitated comparing our reliable, differentiated, and innovative offerings with other evolving foundational tools for AI across various sectors. By leveraging and improving other AI tools using AHT and vice versa, we create robust, accurate, innovative, and novel outcome intelligence solutions ensembles with AHT at the core. Recent improvements in generative AI, for example, are leveraged to decipher novel value provided by our outcomes intelligence AI solutions.

Our primary focus on the health sector allows ReSurfX to deliver highly reliable end-to-end solutions for Pharma and Biotech enterprises, healthcare delivery organizations (e.g., hospitals and payors), and other stakeholders. By improving outcomes across all stages of development (discovery—clinical trial—sale of high-cost products) and medical care, we enable effective treatment choices and patient care with quantitative and AI-based evidence.

This page gives a quick outline about us. You can find detailed information from navigation bar of this website and may links therein.

Rapid fire introduction video.

ReSurfX::vysen - SyrTOP AI solution has direct validation supporting use in prospective prediction of outcomes in healthcare settings. Check out: ReSurfX in 2021 – Best-in-class Outcome Predictors, Innovation Catalysts and ROI Multipliers for an example of prediction insights on drug-drug-interactions that have been flagged by FDA guidance related to co-prescribing based on real-life post-market surveillance (PMS) data.

Our focus is on end-to-end solutions for Pharma and Biotech enterprises and healthcare sector (spanning discovery - clinical trial - high cost product sale and medical care with quantitative evidence). ReSurfX uses proprietary IP supporting our solutions and also has many issued patents. ReSurfX is also leveraging AHT in powerful Adaptive Operating Point Solutions (AOPS), a suite of analytics and prediction functionalities built for environments with lesser compute resources such as at the edges (including smartphones) for use in tailored end-use solutions for rapid, sensitive and accurate decisions with the adaptiveness and personalization that are inherent to AHT.

Below are quick outlines of our" propositions and market value" and "product and validations"

The former is a version used in CIO Review magazine when we were recognized as 20 Most Promising Analytics Vendors.

*please refresh page if BOTH the following pdf documents do not auto-load